Kyle R. Fahrbach
Kyle R. Fahrbach publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Oncology, on topics such as Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases and Chronic Lymphocytic Leukemia Research.
- World rank
- #292,781 of 7,710,434 ranked researchers
- Rank in United States
- #106,464 of 1,627,098
- Works
- 124
- Citations
- 17k
- Citations per work
- 134.5
What does Kyle R. Fahrbach research?
Kyle R. Fahrbach's work is mostly in Medicine (38%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else7762.2%
- Health Sciences4737.8%
- Medicine4737.8%
- 1Surgery8% of their works
- 2Pulmonary and Respiratory Medicine8% of their works
- 3Oncology6% of their works
- 4Cardiology and Cardiovascular Medicine6% of their works
- 5Rheumatology5% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Psoriasis: Treatment and Pathogenesis
- Dermatology and Skin Diseases
- Chronic Lymphocytic Leukemia Research
- Atrial Fibrillation Management and Outcomes
- Spondyloarthritis Studies and Treatments
- Venous Thromboembolism Diagnosis and Management
- Botulinum Toxin and Related Neurological Disorders
- Multiple Sclerosis Research Studies
Which keywords describe Kyle R. Fahrbach's research?
The keywords of their largest research topics: Treatment, Chronic Lymphocytic Leukemia, Filaggrin, Genomic Aberrations, IL-17, Skin Microbiome, TH17 Cells and Ankylosing Spondylitis.
- Neurotoxins
- Diagnostic Criteria
- Antithrombotic Therapy
- Atrial Fibrillation
- Ankylosing Spondylitis
- Skin Microbiome
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Treatment
- Filaggrin
- IL-17
- TH17 Cells
- Anticoagulant Therapy
- Spondyloarthritis
- Botulinum Toxin
- Multiple Sclerosis
- Venous Thromboembolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Treatment102 topics
- Chronic Lymphocytic Leukemia71 topic
- Filaggrin71 topic
- Genomic Aberrations71 topic
- IL-1771 topic
- Skin Microbiome71 topic
- TH17 Cells71 topic
- Ankylosing Spondylitis61 topic
- Anticoagulant Therapy61 topic
- Atrial Fibrillation61 topic
- Spondyloarthritis61 topic
- Antithrombotic Therapy51 topic
- Botulinum Toxin51 topic
- Diagnostic Criteria51 topic
- Multiple Sclerosis51 topic
- Neurotoxins51 topic
- Venous Thromboembolism51 topic
Where does Kyle R. Fahrbach work?
Kyle R. Fahrbach's main affiliation in the publication record is Ithaka Harbors, United States.
How many publications and citations does Kyle R. Fahrbach have?
OpenAlex counts 124 works and 16,684 citations for Kyle R. Fahrbach, an h-index of 35, ranking #292,781 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kyle R. Fahrbach. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.